Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Kyowa Hakko reports antitumor antibiotic UCH15B at Japanese meeting

April 16, 1998

Antitumor illudin analogues discovered at U. of California

April 16, 1998

AnorMED licenses platinum anticancer agent to Zeneca

April 15, 1998

Water-soluble taxane derivatives under evaluation at Yakult Honsha

April 15, 1998

MMP inhibitors particularly active against MMP-13 described by Monsanto

April 15, 1998

Structure and biological activity of UCH9, a novel antitumor antibiotic

April 15, 1998

Antitumor combretastatin A4 derivative reported by Ajinomoto

April 14, 1998

Antiangiogenic ribozyme from Ribozyme and Chiron presented at cancer meeting

April 14, 1998

New bFGF-TK inhibitor from Parke-Davis

April 14, 1998

Taisho's rugatocenones inhibit cell adhesion

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...